In recent trading session, Plus Therapeutics Inc (NASDAQ:PSTV) saw 1.59 million shares changing hands at last check today with its beta currently measuring 0.48. Company’s recent per share price level of $0.93 trading at -$0.28 or -22.78% at last check today assigns it a market valuation of $5.51M. That most recent trading price of PSTV’s stock is at a discount of -187.1% from its 52-week high price of $2.67 and is indicating a premium of 74.19% from its 52-week low price of $0.24. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 50.31 million shares which gives us an average trading volume of 8.57 million if we extend that period to 3-months.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
Upright in the red during last session for losing -22.78%, in the last five days PSTV remained trading in the red while hitting it’s week-highest on Friday, 03/07/25 when the stock touched $0.93 price level, adding 59.74% to its value on the day. Plus Therapeutics Inc’s shares saw a change of -18.75% in year-to-date performance and have moved -35.11% in past 5-day. Plus Therapeutics Inc (NASDAQ:PSTV) showed a performance of -24.03% in past 30-days. Number of shares sold short was 0.14 million shares which calculate 1.23 days to cover the short interests.
Plus Therapeutics Inc (PSTV) estimates and forecasts
This year revenue growth is estimated to rise 10.21% from the last financial year’s standing. 4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.19M for the same. And 3 analysts are in estimates of company making revenue of 1.73M in the next quarter. Company posted 1.31M and 1.68M of sales in current and next quarters respectively a year earlier. Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 68.20% during past 5 years.
Plus Therapeutics Inc (NASDAQ:PSTV)’s Major holders
Insiders are in possession of 2.34% of company’s total shares while institution are holding 11.50 percent of that, with stock having share float percentage of 11.78%. Investors also watch the number of corporate investors in a company very closely, which is 11.50% institutions for Plus Therapeutics Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 34.96 shares of worth $32313.0 or 0.59% of the total outstanding shares. The later fund manager was in possession of 32.54 shares on Dec 31, 2024 , making its stake of worth around $30080.0 in the company or a holder of 0.55% of company’s stock.
